MCID: OBS001
MIFTS: 48

Obstructive Jaundice malady

Category: Gastrointestinal diseases

Aliases & Classifications for Obstructive Jaundice

About this section

Aliases & Descriptions for Obstructive Jaundice:

Name: Obstructive Jaundice 11 13
Jaundice, Obstructive 39 68
Obstructive Hyperbilirubinemia 11
Cholestatic Jaundice Syndrome 11
 
Obstructive Jaundice Nos 11
Jaundice Cholestatic 50
Jaundice Obstructive 50
Cholestatic Jaundice 11

Classifications:



External Ids:

Disease Ontology11 DOID:13603
MeSH39 D041781
NCIt45 C34742

Summaries for Obstructive Jaundice

About this section
MalaCards based summary: Obstructive Jaundice, also known as jaundice, obstructive, is related to b-cell lymphomas and choroiditis, and has symptoms including icterus and jaundice (not of newborn). An important gene associated with Obstructive Jaundice is ALPP (Alkaline Phosphatase, Placental), and among its related pathways are FOXA2 and FOXA3 transcription factor networks and Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include liver, pancreas and lung, and related mouse phenotypes are renal/urinary system and growth/size/body region.

Related Diseases for Obstructive Jaundice

About this section

Diseases related to Obstructive Jaundice via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 355)
idRelated DiseaseScoreTop Affiliating Genes
1b-cell lymphomas29.7F2, GGT1, GPT
2choroiditis29.4ALB, CXCL8, IL6, TNF
3xanthogranulomatous cholecystitis29.3CD79A, CXCL8, TNF
4histiocytosis29.3CD79A, CXCL8, IL6, TNF
5acute monocytic leukemia29.1ALB, F2, GPT, HGF, SLC17A5
6mirizzi syndrome11.1
7cholestasis, benign recurrent intrahepatic11.1
8cholestasis, benign recurrent intrahepatic, 210.9
9bile acid synthesis defect, congenital, 110.9
10adrenocorticotropic hormone deficiency10.9
11pancreatitis10.5
12gastric neuroendocrine tumor type 110.3GPT, SLC17A5
13phaeochromocytoma10.3ALB, TTR
14hepatitis10.3
15vps11-related autosomal recessive hypomyelinating leukodystrophy10.3IL6, TNF
16congenital dyserythropoietic anemia10.3ALB, TNF
17nondystrophic myotonia10.3ALB, F2
18uterine inflammatory disease10.3EDN1, REN
19ringed hair10.3GGT1, GPT
20distal monosomy 14q10.3IL6, REN
21ehlers-danlos syndrome, periodontal type 110.3ALB, TTR
22radiation induced cancer10.3GPT, SLC17A5
23inner ear disease10.3ALB, IL6, TTR
24atopic dermatitis 610.3ALB, CD79A
25migraine with aura10.3IL6, SLC17A5, TNF
26vogt-koyanagi-harada disease10.3GPT, IL6, TNF
27leydig cell hypoplasia10.3IL6, SLC17A5, TNF
28spinocerebellar ataxia 2510.3ALB, IL6, REN
29papilledema10.3IL6, TNF, TTR
30familial progressive hyperpigmentation10.2F2, GPT
31plummer's disease10.2ALB, IL6, TNF
32rift valley fever10.2ALB, IL6, TNF
33colloid adenoma10.2ALB, CD79A
34mansonelliasis10.2ALB, IL6, TNF
35central nervous system leiomyoma10.2ALB, IL6, TTR
36acute necrotizing encephalitis10.2ALB, GGT1, REN
37ischemic optic neuropathy10.2ALB, F2, IL6
38alopecia10.2GGT1, GPT, SLC17A5
39lymphoma10.2
40high-grade dysplasia in patients with barrett esophagus10.2EDN1, REN, SLC17A5
41pulpitis10.2F2, SLC17A5, TNF
42schneiderian carcinoma10.2ALB, CD79A
43autoimmune disease of central nervous system10.2F2, IL6, TNF
44petrositis10.2ALB, EDN1, REN
45pyelitis10.2ALB, F2, GPT
46fallopian tube leiomyosarcoma10.2ALB, F2, GPT
47congenital nystagmus10.2ALB, CD79A, REN
48hypothyroidism, congenital nongoitrous, 510.2GGT1, REN
49central nervous system lymphoma10.2EDN1, IL6, TNF
50acute female pelvic peritonitis10.2CD79A, TTR

Graphical network of the top 20 diseases related to Obstructive Jaundice:



Diseases related to obstructive jaundice

Symptoms & Phenotypes for Obstructive Jaundice

About this section

UMLS symptoms related to Obstructive Jaundice:


icterus, jaundice (not of newborn)

MGI Mouse Phenotypes related to Obstructive Jaundice according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053677.7ALB, CD79A, EDN1, GGT1, IL6, REN
2MP:00053786.9EDN1, F2, GGT1, HGF, IL6, NTS
3MP:00053766.6ALB, CD79A, EDN1, F2, GGT1, IL6

Drugs & Therapeutics for Obstructive Jaundice

About this section

Drugs for Obstructive Jaundice (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 57)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
LactuloseapprovedPhase 41014618-18-211333
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
4-O-b-D-Galactopyranosyl-D-Fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-D-Galactopyranosyl-D-Fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-Fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
 
Bifiteral
Cephulac
D-Lactulose
Lactulosa
Lactulose
Lactulosum
delta-Lactulose
lactulosa
lactulosum
2
CeftriaxoneapprovedPhase 411973384-59-55479530, 5361919
Synonyms:
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
104376-79-6
104376-79-6 (di-hydrochloride salt)
73384-59-5
74578-69-1 (di-hydrochloride salt, hemiheptahydrate)
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
AC-1592
AC1NUIFE
Biotrakson
C06683
C18H18N8O7S3
CEFTRIAXONE SODIUM
CHEBI:29007
CHEMBL161
CID5479530
CTRX
Cefatriaxone
Ceftriaxon
Ceftriaxona
Ceftriaxona [INN-Spanish]
 
Ceftriaxone (INN)
Ceftriaxone (TN)
Ceftriaxone [USAN:JAN]
Ceftriaxone intravenous
Ceftriaxone, Disodium Salt
Ceftriaxone, Disodium Salt, Hemiheptahydrate
Ceftriaxonum
Ceftriaxonum [INN-Latin]
Ceftriazone
D07659
DB01212
DRG-0071
EINECS 277-405-6
LS-150031
Longacef
Longaceph
MolPort-005-933-495
Ro 139904
Ro-13-9904
Ro13-9904
Rocefin
Rocephin
Rocephine
UNII-75J73V1629
ceftriaxone
3
Levofloxacinapproved, investigationalPhase 4236100986-85-4149096
Synonyms:
(−
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-Ofloxacin
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(R)-isomer
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-Ofloxacin
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
)-Ofloxacin
100986-85-4
100986-86-5
28266_FLUKA
28266_SIGMA
AC-7593
AC1L3YF8
Aeroquin
Ambap100986-85-4
BRD-K09471561-001-06-7
BSPBio_002689
C07660
C18H20FN3O4
C18H20FN3O4.H2O
CCRIS 4073
CCRIS 4074
CHEMBL33
CID149096
CPD000466387
Cravit
Cravit (TN)
Cravit Ophthalmic
D08120
DB01137
DR 3354
DR-3355
DR-3355: L-isomer of ofloxacin
DR3355
Elequine
Floxacin
Floxel
Floxin
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HR 355
HR-355
Iquix
KBio2_002199
KBio2_004767
KBio2_007335
KBio3_001909
 
KBioGR_001605
KBioSS_002199
L-Ofloxacin
L-ofloxacin
L0193
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
LEVOFLOXACIN
LFX
LS-133260
LS-171761
LVX
Leroxacin
Lesacin
Levaquin
Levofloxacin
Levofloxacin (INN)
Levofloxacin [USAN:INN:JAN]
Levofloxacin hydrate
Levofloxacin tablet, suspension or intravenous
Levofloxacine
Levofloxacine [INN-French]
Levofloxacino
Levofloxacino [INN-Spanish]
Levofloxacinum
Levofloxacinum [INN-Latin]
Levokacin
Levox
Levoxacin
MLS000759524
MLS001165709
MLS001423977
MP-376
MolPort-002-885-835
Mosardal
NCGC00178529-01
Nofaxin
Ofloxacin
Ofloxacin S-(-)-form
Oftaquix
Quixin
R-Ofloxacin
RWJ 25213-097
RWJ-25213
Reskuin
S-(-)-Ofloxacin
S1940_Selleck
SAM001246758
SMR000466387
SPBio_001891
SPECTRUM1504260
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
Spectrum_001719
Tavanic
Volequin
d-Levofloxacin
4
OfloxacinapprovedPhase 423682419-36-14583
Synonyms:
( -)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(+/-)-Floxin
118120-51-7 (hydrochloride)
33703_FLUKA
33703_RIEDEL
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
82419-36-1
83380-47-6
85344-55-4
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
AB00513820
AC-7616
AC1L1IHM
AKOS001033517
BB_SC-1252
BPBio1_000345
BRD-A24228527-001-05-9
BRN 3657947
BSPBio_000313
BSPBio_003117
Bactocin
C07321
C18H20FN3O4
CCRIS 5233
CHEBI:7731
CHEMBL4
CID4583
CPD000058192
D00453
DB01165
DEXTROFLOXACINE
DL 8280
DL-8280
DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin
Danoflox
DivK1c_000721
EU-0100904
Effexin
Exocin
Exocine
FLOXIN IN DEXTROSE 5%
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
Floxin (TN)
Floxin otic
Floxstat
Fugacin
HMS1568P15
HMS1921H12
HMS2090F07
HMS2092B10
HMS502E03
HOE 280
Hoe-280
I06-0112
I06-0380
IDI1_000721
Inoflox
KBio1_000721
KBio2_001666
KBio2_004234
KBio2_006802
KBio3_002617
KBioGR_000667
KBioSS_001666
Kinflocin
Kinoxacin
LS-133259
Liflox
Lopac0_000904
Loxinter
MLS000028749
MLS001074203
Marfloxacin
Medofloxine
Mergexin
MolPort-000-422-241
MolPort-000-873-068
NCGC00015772-02
NCGC00015772-10
 
NCGC00094219-01
NCGC00094219-02
NCGC00094219-03
NCGC00094219-04
NCGC00094219-05
NCGC00094219-06
NCGC00178284-01
NCGC00178284-02
NINDS_000721
NSC727071
Novecin
Nufafloqo
O 8757
O-Flox
O8757_SIGMA
OFLX
OFX
ORF 18489
ORF-28489
Obide
Occidal
Ocuflox
Ofcin
Oflin
Oflocee
Oflocet
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
Ofloxacin (JP15/USP/INN)
Ofloxacin Otic
Ofloxacin [USAN:BAN:INN:JAN]
Ofloxacin, (S)-Isomer
Ofloxacina
Ofloxacina [DCIT]
Ofloxacine
Ofloxacine [French]
Ofloxacino
Ofloxacino [Spanish]
Ofloxacinum
Ofloxacinum [Latin]
Ofloxin
Ofus
Onexacin
Operan
Oprea1_242882
Orocin
Otonil
Oxaldin
PT 01
Pharflox
Praxin
Prestwick0_000237
Prestwick1_000237
Prestwick2_000237
Prestwick3_000237
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Ru-43280
S1463_Selleck
SAM002264629
SMR000058192
SPBio_001387
SPBio_002234
SPECTRUM1502044
STK256723
Sinflo
Spectrum2_001464
Spectrum3_001499
Spectrum4_000324
Spectrum5_001063
Spectrum_001186
Tabrin
Taravid
Tariflox
Tarivid
Telbit
Tructum
UNII-A4P49JAZ9H
Uro Tarivid
Viotisone
Visiren
WP-0405
XED
Zanocin
ofloxacin
5Renal AgentsPhase 4754
6Topoisomerase InhibitorsPhase 45069
7Cytochrome P-450 Enzyme InhibitorsPhase 43917
8Cytochrome P-450 CYP1A2 InhibitorsPhase 4572
9Anti-Bacterial AgentsPhase 411226
10Antibiotics, AntitubercularPhase 47180
11Anti-Infective AgentsPhase 422062
12Antitubercular AgentsPhase 41343
13
TrioxsalenapprovedPhase 2, Phase 3413902-71-45585
Synonyms:
2',4,8-Trimethylpsoralen
4,5',8-Trimethylpsoralen
4,8,5'-Trimethylpsoralen
6-Hydroxy-beta,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
Trimethylpsoralen
Trioxisaleno
 
Trioxsalen
Trioxysalen
Trioxysalene
Trioxysalenum
Trisoralen
trimethylpsoralen
trioxysalen
trisoralen
14Liver ExtractsPhase 3, Phase 2, Phase 14067
15Dihematoporphyrin EtherPhase 2, Phase 341
16Hematoporphyrin DerivativePhase 2, Phase 330
17
PancrelipaseapprovedPhase 297053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
18
Ursodeoxycholic acidapproved, investigationalPhase 297128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
 
ISO-URSODEOXYCHOLIC ACID
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
19
MentholapprovedPhase 226062216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
20
Neostigmineapproved, vet_approvedPhase 1, Phase 210859-99-44456
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester)
114-80-7 (bromide)
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium
3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium
51-60-5 (methyl sulfate)
59-99-4
AB00053807
AC1L1I7G
Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)
BPBio1_000634
BRD-K18922609-004-04-1
BRN 3615946
BSPBio_000576
Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl- (9CI)
C07258
CAS-114-80-7
CCRIS 3079
CHEBI:7514
CID4456
D08261
DB01400
DivK1c_000165
DivK1c_000198
Eustigmin
Eustigmine
HMS2089A22
HSDB 3921
IDI1_000165
IDI1_000198
InChI=1/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1
Intrastigmina
Juvastigmin
KBio1_000165
KBio1_000198
KBio2_001541
KBio2_004109
KBio2_006677
KBioGR_000623
KBioSS_001541
LS-18452
Lopac-N-2001
 
Lopac0_000816
NCGC00015730-01
NCGC00015730-02
NCGC00015730-03
NCGC00015730-04
NCGC00015730-08
NCGC00021658-03
NCGC00163240-01
NEOSTIGMINE
NINDS_000165
NINDS_000198
Neostigmin
Neostigmine (BAN)
Neostigmine [BAN]
Neostigmine omega
Neostigminum
Prestwick0_000468
Prestwick1_000468
Prestwick2_000468
Prestwick3_000468
Prostigmin
Prostigmin (TN)
Prostigmine
Prozerin
SPBio_001276
SPBio_002515
STL058953
Spectrum2_001278
Spectrum4_000072
Spectrum5_001234
Spectrum_001061
Synstigmin
Syntostigmine
UNII-3982TWQ96G
Vagostigmin
Vagostigmine
ZINC00001792
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium
[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide
[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium
bmse000762
m-Trimethylammoniumphenyldimethylcarbamate
nchembio.188-comp33
sulfonatooxymethane
21
BilirubinPhase 2, Phase 1116635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
22Cholagogues and CholereticsPhase 2130
23pancreatinPhase 2970
24Gastrointestinal AgentsPhase 28402
25Peripheral Nervous System AgentsPhase 1, Phase 223689
26Cholinesterase InhibitorsPhase 1, Phase 2592
27Neurotransmitter AgentsPhase 1, Phase 218340
28Cholinergic AgentsPhase 1, Phase 23992
29Anti-Inflammatory AgentsPhase 1, Phase 210729
30Autonomic AgentsPhase 1, Phase 210150
31Fat Emulsions, IntravenousPhase 1, Phase 297
32Omega 3 Fatty AcidNutraceuticalPhase 1, Phase 21018
33Soy BeanNutraceuticalPhase 1, Phase 2554
34OliveNutraceuticalPhase 1, Phase 2278
35
Sevofluraneapproved, vet_approved50828523-86-65206
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
BRN 2041023
Bax 3084
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
MR6S4
 
MR_6S4
MolPort-001-775-746
NCGC00167421-01
PC4681
Sevofluran
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
UNII-38LVP0K73A
Ultane
Ultane (TN)
ZINC01530810
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
sevoflurane
36
Prednisoneapproved, vet_approved139853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
37
Phenobarbitalapproved5950-06-64763
Synonyms:
11097-06-6
46755-67-3
5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione
5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione
5-Ethyl-5-phenylbarbituric acid
5-Phenyl-5-ethylbarbituric acid
5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
50-06-6
57-30-7 (mono-hydrochloride salt)
AC1L1IWE
AI3-02726
AKOS000605404
Acido 5-fenil-5-etilbarbiturico
Acido 5-fenil-5-etilbarbiturico [Italian]
Adonal
Aephenal
Agrypnal
Amylofene
Antrocol
Aphenylbarbit
Aphenyletten
Arco-Lase Plus
Austrominal
BAS 00226811
BIDD:PXR0061
Barbenyl
Barbilehae (barbilettae)
Barbinal
Barbipenyl
Barbiphen
Barbiphenyl
Barbipil
Barbita
Barbivis
Barbonal
Barbophen
Bardorm
Bartol
Bialminal
Blu-Phen
Blu-phen
C07434
CCRIS 502
CHEBI:8069
CHEMBL40
CID4763
Cabronal
Calmetten
Calminal
Cardenal
Chardonna-2
Chinoin
Codibarbita
Coronaletta
Cratecil
D00506
DB01174
DEA No. 2285
Damoral
Dezibarbitur
DivK1c_000987
Donphen
Dormina
Dormiral
Dormital
Doscalun
Duneryl
EINECS 200-007-0
Elixir of phenobarbital
Ensobarb
Ensodorm
Epanal
Epidorm
Epilol
Episedal
Epsylone
Eskabarb
Etilfen
Euneryl
Fenbital
Fenemal
Fenobarbital
Fenobarbital [INN-Spanish]
Fenobarbitale
Fenobarbitale [DCIT]
Fenosed
Fenylettae
Gardenal
Gardepanyl
Glysoletten
Gustase-Plus
HMS503E15
HSDB 3157
Haplopan
Haplos
Helional
Hennoletten
Henotal
Hypnaletten
Hypnette
Hypno-Tablinetten
Hypnogen
Hypnolone
Hypnoltol
Hysteps
I06-0652
IDI1_000987
InChI=1/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17
KBio1_000987
LS-135
Lefebar
Leonal
Lephebar
Lepinal
Lepinaletten
Levsin PB Drops and Tablets
Linasen
Liquital
Lixophen
Lubergal
Lubrokal
Lumen
Lumesettes
Lumesyn
 
Luminal
Luminal (TN)
Lumofridetten
Luphenil
Luramin
MLS001240232
MolPort-001-783-066
MolPort-003-959-166
Molinal
NCGC00159493-02
NCGC00159493-03
NINDS_000987
NSC 128143
NSC128143
NSC9848
Neurobarb
Nirvonal
Noptil
Nova-Pheno
Nunol
Oprea1_384816
P1636_SIGMA
PHENYLETHYLMALONYLUREA
PHOB
PUBERTAL PHENOBARBITAL STUDY
Pamine PB
Parkotal
Pharmetten
Phazyme-PB
Phen-Bar
Phenaemal
Phenemal
Phenemalum
Phenobal
Phenobarb
Phenobarbital
Phenobarbital (JP15/USP/INN)
Phenobarbital [USAN:INN:JAN]
Phenobarbital, Monosodium Salt
Phenobarbitalum
Phenobarbitalum [INN-Latin]
Phenobarbitalum [INN]
Phenobarbitol
Phenobarbitone
Phenobarbitonum
Phenobarbituric Acid
Phenobarbituric acid
Phenobarbyl
Phenoluric
Phenolurio
Phenomet
Phenonyl
Phenoturic
Phenyl-ethyl-barbituric acid
Phenylaethylbarbitursaeure
Phenylethyl barbituric acid
Phenylethylbarbiturate
Phenylethylbarbituric Acid
Phenylethylbarbituric acid
Phenylethylbarbitursaeure
Phenylethylmalonylurea
Phenyletten
Phenyral
Phob
Polcominal
Promptonal
SK-Phenobarbital
SMR000058986
Seda-Tablinen
Sedabar
Sedicat
Sedizorin
Sedlyn
Sedofen
Sedonal
Sedonal (sedative)
Sedonettes
Sedophen
Sevenal
Sinoratox
Solfoton
Solfoton Talpheno
Solfoton talpheno
Solu-Barb
Sombutol
Somnolens
Somnoletten
Somnosan
Somonal
Spasepilin
Starifen
Starilettae
Stental
Stental Extentabs
Talpheno
Teolaxin
Teoloxin
Thenobarbital
Theoloxin
Triabarb
Tridezibarbitur
Triphenatol
UNII-YQE403BP4D
Valprin 50-PB
Versomnal
WLN: T6VMVMV FHJ F2 FR
Zadoletten
Zadonal
aephe nal
barbapil
barbellen
barbellon
barbilehae
component of Antrocol
component of Bronkotabs
component of Hecadrol
component of Primatene P
component of Slowten
component of Tedral
component of Valpin 50-PB
d ezibarbitur
fen osed
le phebar
phenobarbital
phenobarbital (PB)
phenobarbitone
phenylral
seda-tabl inen
stental exte ntabs
theominal
38Platelet Aggregation Inhibitors2516
39Bile Acids and Salts106
40Anesthetics, Inhalation684
41Central Nervous System Depressants13403
42Anesthetics, General2934
43Dermatologic Agents5806
44Hematoporphyrins14
45Ether61
46Anesthetics9596
47Photosensitizing Agents492
48Antibodies6394
49Immunoglobulins6394
50Immunoglobulin G275

Interventional clinical trials:

(show all 46)
idNameStatusNCT IDPhase
1Randomised Trial Comparing Metal and Plastic Biliary Stents Stents for Palliating Malignant JaundiceUnknown statusNCT00731419Phase 4
2Human Kidney Histopathology in Obstructive JaundiceCompletedNCT01090193Phase 4
3Covered vs. Uncovered SEMS for Occluded Biliary Metal StentsCompletedNCT01315522Phase 4
4Antibiotics to Decrease Post ERCP CholangitisRecruitingNCT03087656Phase 4
5Preoperative Biliary Drainage for the Lower Malignant Obstructive JaundiceUnknown statusNCT01744938Phase 3
6RFA RCT for Pancreatic or Bile Duct CancerUnknown statusNCT02166190Phase 3
7Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.CompletedNCT00391183Phase 2, Phase 3
8Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct StricturesRecruitingNCT01721174Phase 2, Phase 3
9Photodynamic Therapy (PDT) for Palliation of CholangiocarcinomaRecruitingNCT01755013Phase 2, Phase 3
10WallFlex Biliary Fully Covered (FC) Benign Stricture StudyActive, not recruitingNCT01014390Phase 3
11Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar ObstructionWithdrawnNCT01622803Phase 3
12The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive JaundiceUnknown statusNCT01688375Phase 2
13Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive JaundiceUnknown statusNCT01275768Phase 1, Phase 2
14Evaluation of Preoperative Biliary Drainage Before PancreatoduodenectomyUnknown statusNCT01941342Phase 2
15Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors.CompletedNCT02166840Phase 2
16Radiofrequency Ablation for Biliopancreatic MalignancyCompletedNCT02468076Phase 2
17Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.RecruitingNCT02279147Phase 1, Phase 2
18EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal StentRecruitingNCT03002051Phase 2
19SMOFlipid to Lessen the Severity of Neonatal CholestasisTerminatedNCT02721277Phase 1, Phase 2
20Immune Function in Patients With Obstructive JaundiceUnknown statusNCT01367821
21Evaluation of Immune Function in Biliary Atresia Children With Prolonged JaundiceUnknown statusNCT00155194
22Percutaneous Transhepatic Cholangiography Versus Endoscopic Ultrasound Guided Biliary DrainageUnknown statusNCT01686425
23Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary CancersCompletedNCT01134276
24Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography: Precut Versus Conventional CannulationCompletedNCT02477228
25Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular CarcinomaCompletedNCT01506115
26Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder CancerCompletedNCT00409864
27Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)CompletedNCT00196105
28Outcome of Carbon Dioxide Versus Air Insufflations During Endoscopic Retrograde Cholangiopancreatography (ERCP)CompletedNCT01321203
29Biliary Atresia, Hepatic Buffer Response and SevofluraneCompletedNCT02471209
30Early Versus Late Cholecystectomy After Clearance of Common Bile Duct StonesCompletedNCT02460315
31Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct StricturesCompletedNCT01580709
32Expression of BCRP in Icteric PatientsCompletedNCT00295360
33Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by CorticosteroidsRecruitingNCT02797665
34Comparison of Metal and Plastic Stents for Preoperative Biliary DecompressionRecruitingNCT01191814
35Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency AblationRecruitingNCT03133026
36Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary DecompressionRecruitingNCT01675908
37Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary ObstructionRecruitingNCT02937246
38The Necessity of Bile Cultures in Patients With Acute CholangitisRecruitingNCT02601417
39Study of Abdominal Drainage in LCBDE+PCRecruitingNCT03120754
40A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary ObstructionRecruitingNCT02659852
41Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable StudyRecruitingNCT02646514
42Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersRecruitingNCT01438385
43Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary StenosisEnrolling by invitationNCT02841800
44A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary ObstructionTerminatedNCT01514058
45Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCPWithdrawnNCT01439685
46Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD StentWithdrawnNCT01875549

Search NIH Clinical Center for Obstructive Jaundice


Cochrane evidence based reviews: jaundice, obstructive

Genetic Tests for Obstructive Jaundice

About this section

Anatomical Context for Obstructive Jaundice

About this section

MalaCards organs/tissues related to Obstructive Jaundice:

36
Liver, Pancreas, Lung, Lymph node, Brain, Myeloid, B cells

Publications for Obstructive Jaundice

About this section

Articles related to Obstructive Jaundice:

(show top 50)    (show all 704)
idTitleAuthorsYear
1
My First Patient: More Than Obstructive Jaundice. (28027099)
2017
2
Identification of bile survivin and carbohydrate antigen 199 in distinguishing cholangiocarcinoma from benign obstructive jaundice. (27874286)
2017
3
Obstructive Jaundice Caused by Hepatic Torsion in an Infant with Congenital Diaphragmatic Hernia. (28082781)
2017
4
Spontaneous Intramural Duodenal Hematoma: Pancreatitis, Obstructive Jaundice, and Upper Intestinal Obstruction. (27891286)
2016
5
Obstructive jaundice caused by a pancreaticoduodenal pseudoaneurysm. (27324520)
2016
6
Incidental Diagnosis of MEN1 Syndrome in a Pediatric Patient Presenting With Obstructive Jaundice and Abdominal Pain. (27144202)
2016
7
Temporary placement of a covered duodenal stent can avoid riskier anterograde biliary drainage when ERCP for obstructive jaundice fails due to duodenal invasion. (27324333)
2016
8
Hepatocellular Carcinoma With Budd-Chiari Syndrome and Obstructive Jaundice: A Therapeutic Challenge. (27661754)
2016
9
Aggressive Surgery for Locally Advanced Gallbladder Cancer with Obstructive Jaundice: Result of a Prospective Study. (26918527)
2016
10
Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study. (27391646)
2016
11
Immune dysfunction in patients with obstructive jaundice before and after endoscopic retrograde cholangiopancreatography. (27252406)
2016
12
Murine model of long-term obstructive jaundice. (27916350)
2016
13
Obstructive Jaundice from Metastatic Squamous Cell Carcinoma of the Lung. (27389381)
2016
14
Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients. (27241392)
2016
15
Erratum to: Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort study. (27651023)
2016
16
Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. (27400651)
2016
17
Obstructive Jaundice as a Complication of Macrocystic Serous Cystadenoma of the Pancreas. (27550882)
2016
18
Uterine cancer presenting as obstructive jaundice. (27462179)
2016
19
Plasma BNP level combined with surgical Apgar score to predict operative major cardiac adverse events in malignant obstructive jaundice patients. (27882019)
2016
20
Overexcited MaxiK and KATP channels underlie obstructive jaundice-induced vasoconstrictor hyporeactivity of arterial smooth muscle. (28000721)
2016
21
Strongyloides stercoralis Infection Causing Obstructive Jaundice and Refractory Pancreatitis: A Lesson Learned from a Case Study. (27477420)
2016
22
Polycystic liver disease complicated by obstructive jaundice. (26718392)
2016
23
Erratum to: Intermittent Obstructive Jaundice Following Gastric Band Placement. (26883930)
2016
24
Bile acid receptor TGR5 overexpression is associated with decreased intestinal mucosal injury and epithelial cell proliferation in obstructive jaundice. (28034761)
2016
25
Primary Bile Duct Melanoma Causing Obstructive Jaundice. (27807580)
2016
26
Comment re: "Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting". (27329667)
2016
27
Obstructive jaundice in autoimmune pancreatitis can be safely treated with corticosteroids alone without biliary stenting. (27107633)
2016
28
An interesting case of obstructive jaundice. (27728263)
2016
29
Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice. (27006124)
2016
30
An Unusual Case of Obstructive Jaundice Owing to an Extrabiliary Mass. (27814999)
2016
31
The role of growth factors on hepatic damage in rats with obstructive jaundice. (27540507)
2016
32
A pilot study of intraluminal brachytherapy using (125)I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice. (27364870)
2016
33
Cost Effectiveness of Metal Stents in Relieving Obstructive Jaundice in Patients with Pancreatic Cancer. (28025817)
2016
34
Value and Accuracy of Multidetector Computed Tomography in Obstructive Jaundice. (27429673)
2016
35
Current Status of Percutaneous Transhepatic Biliary Drainage in Palliation of Malignant Obstructive Jaundice: A Review. (27803558)
2016
36
Gastrointestinal bleeding and obstructive jaundice: Think of hepatic artery aneurysm. (27358680)
2016
37
The protective effects of pomegranate on liver and remote organs caused by experimental obstructive jaundice model. (26957283)
2016
38
Value of percutaneous transhepatic cholangiobiopsy for pathologic diagnosis of obstructive jaundice: analysis of 826 cases. (26917786)
2016
39
Ginsenoside Rg1 prevents cerebral and cerebellar injury induced by obstructive jaundice in rats via inducing expression of TIPE-2. (26592478)
2016
40
Bilateral intrahepatic bile duct compression by giant non-parasitic hepatic cyst: A rare cause of obstructive jaundice. (27296070)
2016
41
Combined Stent Insertion and High-intensity Focused Ultrasound Ablation for Patients With Malignant Obstructive Jaundice. (27783026)
2016
42
An uncommon cause of obstructive jaundice: An infrequent neoplastic etiology. (27637596)
2016
43
Hydrogen-rich saline protects against mitochondrial dysfunction and apoptosis in mice with obstructive jaundice. (26936224)
2016
44
Novel approach to recanalizing an occluded cystic duct after cholecystoduodenostomy by lumen-apposing metal mesh stent for malignant obstructive jaundice. (26684605)
2016
45
Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress. (26236101)
2015
46
Unusual cause of obstructive jaundice revealed by endoscopic ultrasound guided fine-needle aspiration of mediastinal lymph node. (25789290)
2015
47
Extra-osseous Ewing's sarcoma presenting as obstructive jaundice. (26591961)
2015
48
Obstructive jaundice secondary to paracoccidioidomycosis. (26591954)
2015
49
Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats. (25593463)
2015
50
CA 19-9 in the presence of obstructive jaundice due to Mirizzi syndrome. (25739181)
2015

Variations for Obstructive Jaundice

About this section

Expression for genes affiliated with Obstructive Jaundice

About this section
Search GEO for disease gene expression data for Obstructive Jaundice.

Pathways for genes affiliated with Obstructive Jaundice

About this section

GO Terms for genes affiliated with Obstructive Jaundice

About this section

Cellular components related to Obstructive Jaundice according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.9CD79A, F2, IL6, TNF
2extracellular regionGO:00055766.8ALB, CXCL8, EDN1, F2, HGF, IL6
3extracellular spaceGO:00056156.1ALB, CXCL8, EDN1, F2, GGT1, GPT

Biological processes related to Obstructive Jaundice according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.5IL6, TNF
2negative regulation of lipid storageGO:001088810.4IL6, TNF
3positive regulation of chemokine productionGO:003272210.4IL6, TNF
4negative regulation of hormone secretionGO:004688810.3EDN1, IL6
5cellular response to hepatocyte growth factor stimulusGO:003572910.2HGF, IL6
6positive regulation of nitric oxide biosynthetic processGO:004542910.0EDN1, IL6, TNF
7cellular protein metabolic processGO:004426710.0ALB, F2, IL6, TTR
8positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.9EDN1, IL6, TNF
9cellular response to interleukin-1GO:00713479.8CXCL8, EDN1, IL6
10positive regulation of smooth muscle cell proliferationGO:00486619.4EDN1, IL6, TNF

Molecular functions related to Obstructive Jaundice according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051258.9CXCL8, EDN1, IL6, TNF

Sources for Obstructive Jaundice

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet